{"id":"W2889905232","doi":"10.1182/bloodadvances.2018015677","title":"A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; Juravinski Hospital; London Health Sciences Centre; Population Health Research Institute; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Cytarabine; Medicine; Tolerability; Myeloid leukemia; Internal medicine; Acute leukemia; Refractory (planetary science); Pharmacology; Oncology; Leukemia; Adverse effect; Gastroenterology; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005953459,0.0002602538,0.0004984763,0.0003985623,0.00008062414,0.00002620416,0.0001705473,0.00009006916,0.00005970847],"category_scores_gemma":[0.0002736241,0.000180967,0.00003083884,0.001061787,0.0002237989,0.0004944483,0.00005601627,0.0004524845,0.0000249031],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004638173,"about_ca_system_score_gemma":0.0008246232,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006778148,"about_ca_topic_score_gemma":0.0003312707,"domain_scores_codex":[0.9974915,0.0001223592,0.0004478329,0.0005133119,0.0009112821,0.0005137397],"domain_scores_gemma":[0.9988034,0.000125701,0.0001853061,0.0003562185,0.0003978234,0.0001315256],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6651329,0.01106752,0.2151702,0.0002368418,0.000498411,0.0006305847,0.001770509,0.00007923545,0.01078015,0.0001522407,0.0001278055,0.09435355],"study_design_scores_gemma":[0.8329955,0.0798877,0.07351988,0.0006703792,0.0003282962,0.00003775613,0.0001701057,0.001647774,0.009534881,0.0001403467,0.0006436755,0.0004237293],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958537,0.0001362638,0.00008059372,0.0002666904,0.00008674276,0.002241465,0.00001154236,0.00005521714,0.001267803],"genre_scores_gemma":[0.9926718,0.00005367108,0.006255929,0.0001388664,0.0002478254,0.0001999663,0.0001207539,0.00004504646,0.0002660848],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1678626,"threshold_uncertainty_score":0.7379622,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01813438728361201,"score_gpt":0.3399382594057945,"score_spread":0.3218038721221825,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}